RACHAEL WALKER: Open Payments
NPI 1487241584 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 8 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $285 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $132 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Incyte Corporation | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: RYBREVANT, KEYTRUDA, KEYTRUDA QLEX.
Industry payments across MD — which companies pay providers there.
